July 1989
Volume 30, Issue 7
Free
Articles  |   July 1989
Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat.
Author Affiliations
  • W L Haynes
    Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina.
  • A D Proia
    Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina.
  • G K Klintworth
    Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina.
Investigative Ophthalmology & Visual Science July 1989, Vol.30, 1588-1593. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      W L Haynes, A D Proia, G K Klintworth; Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat.. Invest. Ophthalmol. Vis. Sci. 1989;30(7):1588-1593.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

We used computerized image analysis to evaluate quantitatively the ability of topically applied corticosteroids (dexamethasone sodium phosphate, prednisolone acetate), cyclooxygenase inhibitors (flurbiprofen, indomethacin, ketorolac), lipoxygenase inhibitors (REV 5901, esculetin, quercetin), and dual cyclooxygenase/lipoxygenase inhibitors (BW 755C, BW A540C) to reduce corneal neovascularization in the rat induced by silver/potassium nitrate cauterization. Significant decreases in the neovascular response were found with corticosteroids and cyclooxygenase inhibitors. A complete dose-response curve was performed for a representative compound from each class. Dexamethasone was found to be superior to flurbiprofen in its ability to reduce neovascularization in this model, while no significant inhibition was noted with either REV 5901 or BW 755C, even at high doses. We conclude that the corneal angiogenic response in this model can be reduced by inhibition of cyclooxygenase as well as by other mechanisms that are steroid-dependent but are, as yet, poorly defined.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×